The University of Texas M. D. Anderson Cancer Center Urology Fellowship has played a leadership role in the development of highly qualified Urologic physician-scientists, who have been a significant resource to the medical care of the United States. This three-year fellowship has attracted outstanding applicants who have garnered notable awards during their training and then obtained prestigious academic positions ensuring continued advances in the care of patients with urologic cancers. The three-year training program integrates """"""""bench research"""""""" and clinical training resulting in translational efforts that will ultimately result in improvements in routine patient care. Our two SPOREs focused on prostate and bladder cancer are evidence of the excellence in translational research in the Genitourinary Program of the M. D. Anderson Cancer Center. ? ? The primary goal of this program is to train academic urologic oncologists, who are excellent clinicians, surgeons, and scientists. Fellows completing this program will be capable of establishing or upgrading academic Urologic Oncology programs in major teaching institutions. To accomplish this task, the graduating fellows will need to obtain organizational, leadership, and didactic skills along with clinical and research expertise. The success of this T32 training program is based upon our ability to provide the trainee with a working knowledge of the laboratory and clinically defined biology of genitourinary cancer. This understanding will enable the trainee to critically evaluate current methods of cancer prevention, diagnosis, and treatment and develop improved strategies based upon rigorous laboratory data, translational research, and clinical observations. ? ? An important but secondary goal of our training program is a post-doctoral laboratory training effort, which has included both physicians and research scientists. Post-doctoral fellows have the opportunity to work closely with clinicians during their training. This association with outstanding clinicians will help integrate their future research into translational efforts. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
2T32CA079449-06
Application #
6892283
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gorelic, Lester S
Project Start
2000-08-01
Project End
2010-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
6
Fiscal Year
2005
Total Cost
$258,535
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Urology
Type
Other Domestic Higher Education
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Dinney, Colin P N; Fisher, Mark B; Navai, Neema et al. (2013) Phase I trial of intravesical recombinant adenovirus mediated interferon-?2b formulated in Syn3 for Bacillus Calmette-Guérin failures in nonmuscle invasive bladder cancer. J Urol 190:850-6
Black, Peter C; Dinney, Colin P N; Brown, Gordon A et al. (2011) The role of radical cystectomy in patients with clinical T4b bladder cancer. Urol Oncol 29:157-61
Sterba, Katherine Regan; Swartz, Richard J; Basen-Engquist, Karen et al. (2011) Long-term quality of life after radical prostatectomy in wives of men in the postoperative adjuvant androgen deprivation trial. Support Care Cancer 19:1117-24
Chiong, Edmund; Dadbin, Ali; Harris, Loleta D et al. (2009) The use of short tandem repeat profiling to characterize human bladder cancer cell lines. J Urol 181:2737-48
Kassouf, Wassim; Agarwal, Piyush K; Grossman, H Barton et al. (2009) Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy. Urology 73:147-52
Svatek, Robert S; Kamat, Ashish M; Dinney, Colin P (2009) Novel therapeutics for patients with non-muscle-invasive bladder cancer. Expert Rev Anticancer Ther 9:807-13
Fisher, M B; Zhang, X-Q; McConkey, D J et al. (2009) Measuring soluble forms of extracellular cytokeratin 18 identifies both apoptotic and necrotic mechanisms of cell death produced by adenoviral-mediated interferon alpha: possible use as a surrogate marker. Cancer Gene Ther 16:567-72
Kassouf, Wassim; Agarwal, Piyush K; Herr, Harry W et al. (2008) Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol 26:121-6
Kassouf, Wassim; Spiess, Philippe E; Brown, Gordon A et al. (2007) P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors. Eur Urol 52:769-74
Black, Peter C; Basen-Engquist, Karen; Wang, Xuemei et al. (2007) A randomized prospective trial evaluating testosterone, haemoglobin kinetics and quality of life, during and after 12 months of androgen deprivation after prostatectomy: results from the Postoperative Adjuvant Androgen Deprivation trial. BJU Int 100:63-9

Showing the most recent 10 out of 13 publications